News

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
Adaptimmune Therapeutics plans to drastically cut its workforce, including half of its C-suite, in conjunction with the sale ...
Kennedy has since announced that HHS would reverse 20% of the cuts across the agency. Amid news reports describing the layoffs at the FDA, Kennedy did not specify how many people would be reinstated.
After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans ...
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Medical Device Network on MSN20h
AI at the FDA: help or hindrance?
The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.
Sarepta Therapeutics announces layoffs of 493 employees, including 80 in Franklin County, amid restructuring efforts and ...
This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...
Kennedy has since announced that HHS would reverse 20% of the cuts across the agency. Amid news reports describing the layoffs at the FDA, Kennedy did not specify how many people would be reinstated.